Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yusnelkis Milanés-Guisado

No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients

PLoS ONE

Multidisciplinary

2018

English

Absolute CD4+ T Cell Count Overstate Immune Recovery Assessed by CD4+/CD8+ Ratio in HIV-infected Patients on Treatment

PLoS ONE

Multidisciplinary

2018

English

Related publications

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Infection and Drug Resistance

Infectious Diseases

Pharmacology

2019

English

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

AIDS Research and Human Retroviruses

English

Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects

European Journal of Endocrinology

English

Switch From Enfuvirtide to Raltegravir in Virologically Suppressed HIV-1 Infected Patients: Effects on Level of Residual Viremia and Quality of Life

Journal of Clinical Virology

Virology

Infectious Diseases

2009

English

Nevirapine-Raltegravir Combination, a NRTI and PI/r Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-infected Patients

English

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

English

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

AAPS Journal

Pharmaceutical Science

2012

English

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

Journal of the International AIDS Society

English

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients

Journal of the International AIDS Society

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yusnelkis Milanés-Guisado

No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients

Absolute CD4+ T Cell Count Overstate Immune Recovery Assessed by CD4+/CD8+ Ratio in HIV-infected Patients on Treatment

Related publications

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects

Switch From Enfuvirtide to Raltegravir in Virologically Suppressed HIV-1 Infected Patients: Effects on Level of Residual Viremia and Quality of Life

Nevirapine-Raltegravir Combination, a NRTI and PI/r Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-infected Patients

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients